Cells and cytokines in immunotherapy and gene therapy of cancer

被引：0

作者：

Pawelec, G

Rees, RC

Kiessling, R

Madrigal, A

Dodi, A

Baxevanis, C

Gambacorti-Passerini, C

Masucci, G

Zeuthen, J

机构：

[1] Univ Tubingen, Sch Med, Sect Transplantat Immunol, Tubingen Ageing & Tumour Immunol Grp, D-72076 Tubingen, Germany

[2] Nottingham Trent Univ, Fac Sci & Math, Dept Life Sci, Nottingham NG1 4BU, England

[3] Karolinska Inst, MTC, Stockholm, Sweden

[4] Royal Free Hosp, Anthony Nolan Bone Marrow Trust, London NW3 2QG, England

[5] Hellen Anticanc Inst, Dept Immunol, Athens, Greece

[6] Ist Nazl Studio & Cura Tumori, Div Expt Oncol D, I-20133 Milan, Italy

[7] Danish Canc Soc, Dept Tumor Cell Biol, Div Canc Biol, Copenhagen, Denmark

来源：

CRITICAL REVIEWS IN ONCOGENESIS | 1999年 / 10卷 / 1-2期

关键词：

cancer therapy; gene therapy; tumor antigen; immunosurveillance; tumor rejection; T-cell-mediated immunity; cytokines; immunotherapy; adoptive immunortherapy; active immunotherapy;

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

An enormous effort using a great variety of approaches has been undertaken in the last decade to translate basic and clinical research into successful cancer therapies. This review summarizes recent results of experiments and trials using cellular and cytokine therapy, as well as gene therapy, to exploit immune responses to tumors.

引用

页码：83 / 127

页数：45

共 403 条

[1] LYMPHOCYTE INFILTRATES AS A PROGNOSTIC VARIABLE IN FEMALE BREAST-CANCER [J].

AALTOMAA, S ;

LIPPONEN, P ;

ESKELINEN, M ;

KOSMA, VM ;

MARIN, S ;

ALHAVA, E ;

SYRJANEN, K .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) :859-864

[2] Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity [J].

Abdel-Wahab, Z ;

DeMatos, P ;

Hester, D ;

Dong, XD ;

Seigler, HF .

CELLULAR IMMUNOLOGY, 1998, 186 (01) :63-74

[3] Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations [J].

Abrams, SI ;

Khleif, SN ;

Bergmann-Leitner, ES ;

Kantor, JA ;

Chung, Y ;

Hamilton, JM ;

Schlom, J .

CELLULAR IMMUNOLOGY, 1997, 182 (02) :137-151

[4] LYSIS OF AUTOLOGOUS MELANOMA-CELLS BY TUMOR-INFILTRATING LYMPHOCYTES - ASSOCIATION WITH CLINICAL-RESPONSE [J].

AEBERSOLD, P ;

HYATT, C ;

JOHNSON, S ;

HINES, K ;

KORCAK, L ;

SANDERS, M ;

LOTZE, M ;

TOPALIAN, S ;

YANG, J ;

ROSENBERG, SA .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (13) :932-937

[5] Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy [J].

AlexanderMiller, MA ;

Leggatt, GR ;

Berzofsky, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4102-4107

[6] DENDRITIC CELLS GENERATED FROM PERIPHERAL-BLOOD TRANSFECTED WITH HUMAN TYROSINASE INDUCE SPECIFIC T-CELL ACTIVATION [J].

ALIJAGIC, S ;

MOLLER, P ;

ARTUC, M ;

JURGOVSKY, K ;

CZARNETZKI, BM ;

SCHADENDORF, D .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) :3100-3107

[7]

ALLIONE A, 1994, CANCER RES, V54, P6022

[8]

Allison J, 1998, EUR J IMMUNOL, V28, P949, DOI 10.1002/(SICI)1521-4141(199803)28:03<949::AID-IMMU949>3.0.CO

[9]

2-H

[10]

ANDERSON DO, 1995, CANCER GENE THER, V2, P622

← 1 2 3 4 5 6 7 8 9 10 →